Inflammatory Bowel Diseases Clinical Trial
Official title:
Does the Use of Point of Care Ultrasound During Inflammatory Bowel Disease Clinic Appointments Change Management, Speed up Treatment Decisions and Save Money: a Feasibility and Service Development Study
NCT number | NCT05838196 |
Other study ID # | 155436 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 24, 2023 |
Est. completion date | November 1, 2024 |
Study to determine whether the use of an ultrasound completed during an inflammatory bowel disease (IBD) clinic will speed up diagnosis, treatment initiation, reduce complications, save money and reduce investigations compared with our current standard of care.
Status | Recruiting |
Enrollment | 114 |
Est. completion date | November 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility | Inclusion Criteria: - Age 16 years or above - Attending IBD clinic face-to-face - Able to give informed consent. - Belonging to one of the following groups: 1. New patients with high clinical suspicion of IBD 2. Known UC/IBD-U and possible flare 3. Known Crohn's and possible flare 4. Known IBD and assessing response to a new medication or following surgery 5. Known IBD and clinician planning endoscopic or radiological investigations Exclusion Criteria: - Inflammatory bowel disease limited to proctitis with no clinical suspicion of extension |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University College London Hospitals NHS Trust | London |
Lead Sponsor | Collaborator |
---|---|
University College, London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare time to definitive IBD-related treatment initiation with the use of POCUS compared to standard of care | Time in days for when a new medication is started, dose changed, medication stopped, or surgery performed following the clinic appointment | 6 months | |
Secondary | Does point of care ultrasound change clinical decision making in the IBD clinic | Does the clinical decision made before ultrasound differ from that following ultrasound. | Immediate | |
Secondary | Compare sensitivity and specificity of POCUS to identify active disease with standard of care investigations (MRI, ultrasound, endoscopy) | Using formalised imaging or endoscopy as gold standard for determining disease activity, compare findings on POCUS to determine sensitivity and specificity | 6 months | |
Secondary | Compare healthcare resource utilisation including outpatient appointments, need for further investigations and admissions in patients receiving POCUS or standard of care | Using NHS cost tariffs, estimated costs for participants following standard of care to those receiving POCUS over the year following enrolment | 1 year | |
Secondary | Compare findings at POCUS when performed by a gastroenterologist or a radiologist | POCUS will be performed by gastroenterologists or radiologist and outcomes on sensitivity/specificity will be compared between the two | 6 months | |
Secondary | Compare clinical disease activity scores when POCUS is used compared with standard of care | Using disease activity score questionnaires (HBI (If Crohn's disease) or SCCAI (If ulcerative Colitis)) at baseline and six months. | 6 months | |
Secondary | Compare use of steroids with POCUS compared with standard of care | Number of courses of steroids and total steroid dose over the duration of the trial | 1 year | |
Secondary | Compare haemaglobin levels when POCUS is used compared with standard of care | Are there significant difference between the change in haemaglobin from baseline to six months in the POCUS group compared with standard of care | 6 months | |
Secondary | Compare CRP levels when POCUS is used compared with standard of care | Are there significant difference between the change in CRP from baseline to six months in the POCUS group compared with standard of care | 6 months | |
Secondary | Compare Platelets when POCUS is used compared with standard of care | Are there significant difference between the change in platelets from baseline to six months in the POCUS group compared with standard of care | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Active, not recruiting |
NCT04989907 -
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Active, not recruiting |
NCT04990258 -
A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
|
||
Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
Enrolling by invitation |
NCT06015789 -
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
|
||
Recruiting |
NCT06065995 -
StoMakker Mobile Application
|
N/A | |
Recruiting |
NCT03282786 -
Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease
|
N/A | |
Recruiting |
NCT06002074 -
SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases
|
N/A | |
Recruiting |
NCT04960826 -
Study of an Environmental Risk Factor in Crohn's Disease
|
||
Recruiting |
NCT05413941 -
Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Completed |
NCT00721812 -
A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
|
Phase 1 | |
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
Recruiting |
NCT04991324 -
Cholecalciferol Comedication in IBD - the 5C-study
|
Phase 3 | |
Completed |
NCT03173144 -
Chronic Inflammatory Disease, Lifestyle and Treatment Response
|
||
Not yet recruiting |
NCT05043818 -
A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
|
||
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT02874365 -
Intestinal Stem Cells Characterization
|
N/A |